Royce & Associates’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-27,432
Closed -$1.04M 1273
2017
Q2
$1.04M Hold
27,432
0.01% 965
2017
Q1
$1.34M Sell
27,432
-17,800
-39% -$812K 0.01% 937
2016
Q4
$1.53M Hold
45,232
0.01% 873
2016
Q3
$1.71M Sell
45,232
-5,000
-10% -$188K 0.01% 841
2016
Q2
$1.69M Hold
50,232
0.01% 837
2016
Q1
$1.6M Sell
50,232
-58,000
-54% -$1.89M 0.01% 863
2015
Q4
$4.04M Sell
108,232
-29,700
-22% -$1.12M 0.02% 683
2015
Q3
$5.24M Sell
137,932
-65,000
-32% -$2.28M 0.03% 633
2015
Q2
$5.81M Sell
202,932
-1,878,438
-90% -$52.3M 0.02% 698
2015
Q1
$58.3M Sell
2,081,370
-2,566,370
-55% -$72.1M 0.22% 117
2014
Q4
$129M Sell
4,647,740
-2,081,435
-31% -$51.6M 0.45% 43
2014
Q3
$150M Buy
6,729,175
+73,150
+1% +$1.86M 0.51% 36
2014
Q2
$193M Buy
6,656,025
+540,825
+9% +$14.4M 0.58% 25
2014
Q1
$174M Buy
6,115,200
+1,515,358
+33% +$50.1M 0.51% 30
2013
Q4
$178M Sell
4,599,842
-237,303
-5% -$8.49M 0.51% 30
2013
Q3
$162M Buy
4,837,145
+784,480
+19% +$25M 0.48% 32
2013
Q2
$125M Buy
+4,052,665
New +$136M 0.39% 57

Other funds holding MDCO